Jim Cramer Recommends Two Stocks Sees Nearly 20 Upside in One Disneys Ahsoka Season 2 Shows Cost Discipline 30 Cheaper Than The Acolyte Puig Shares Tumble as Este Lauder Takeover Talks Collapse European Markets Edge Higher Gold Rebounds as Market Sentiment Shifts Toward Slower US Economic Growth Knightscope Secures 38 Million in New and Recurring Contracts Across Eight Industry Verticals Pokmon Card Market Surge Nostalgia Speculation and Record Sales Reshape Collectibles Two Harbors Investments Corp TWOD Q1 2026 Earnings EPS Surges Past Estimates in Resilient Quarter Dropbox Q1 2026 Earnings EPS Beat Drives Optimism Amidst Broader Market Headwinds American Financial Group Q1 2026 Earnings EPS Misses Estimates by 36 Stock Edges Lower OLLI Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Dips Via Transportation Inc VIA Q1 2026 Earnings Narrower Loss Beats Estimates Amid Strategic Shift BankUnited BKU Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Potential Underlying Strength GSI Technology GSIT Surges 474 as Momentum Builds Near Key Resistance Costco Holds Near 1007 as Modest Gains Reflect Steady Retail Demand Airship AI Holdings Inc AISP Faces Resistance as Shares Slide 313 Hongli Group HLP Falls 33 as Shares Approach Key 042 Support Zone Nuveen Churchill Direct Lending Corp NCDL Edges Higher as Support Holds Firm Amazon UK Boss Blames Education System Not Young People for Unemployment RSG Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Sports Entertainment Gaming Global SEGG Drops 545 as Shares Test Crucial Support Near 181 Landstar System Inc LSTR Q1 2026 Earnings Modest EPS Beat Amidst Revenue Uncertainty RWTN Q1 2026 Earnings EPS Misses Estimates Stock Rises 085 TVTX Q1 2026 Earnings EPS Misses Estimates as Clinical Costs Weigh on Results Stock Surges 78 LE Q1 2026 Earnings Earnings Miss Weighs on Outlook Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress VALN Q1 2026 Earnings EPS Misses Estimates as Stock Rises Amid Operational Developments BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility